Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,354.40 +121.18 0.80%
S&P 500 1,667.47 +17.00 1.03%
Nasdaq 3,498.97 +33.72 0.97%
Ticker Volume Price Price Delta
STOXX 50 2,817.99 +11.29 0.40%
FTSE 100 6,723.06 +35.26 0.53%
DAX 8,398.00 +28.13 0.34%
Ticker Volume Price Price Delta
Nikkei 15,360.80 +222.69 1.47%
Hang Seng 23,459.80 +377.13 1.63%
S&P/ASX 200 5,209.00 +28.23 0.54%
  • Exchange: Natl India
  • Sector: Consumer, Non-cyclical
  • Industry: Pharmaceuticals
  • Sub-Industry: Medical-Drugs

Panacea Biotec Ltd

+ Add to Watchlist

PNCB:IN

110.95 INR 2.70 2.49%

As of 02:10:03 ET on 05/20/2013.

Company Profile for Panacea Biotec Ltd (PNCB)

Panacea Biotec Limited operates a pharmaceutical company in India, which manufactures a variety of drugs that are distributed internationally. The Company's products are available in an assortment of forms, including tablets, capsules, dry powder injectables, vaccines, gels, and syrups. Pancea Biotec's key products include a Hepatitis B vaccine and drugs for diabetes management.

Contact Information

Panacea Biotec Ltd

Ambala Chandigarh Highway
Lalru
Punjab, 140501
India
Phone: 91-11-4167-9000
Fax: 91-11-4167-9070

Key Executives for Panacea Biotec Ltd (PNCB)

Soshil Kumar JainChairmanRavinder Kumar JainManaging Director
Rajesh JainJoint Managing DirectorSandeep JainJoint Managing Director
Sumit JainDir:Ops & ProjectsPartha Sarathi DeCFO/Head:IT & BPR
I K SharmaDeputy Gen Mgr:AccountsVinod GoelGen Mgr:Legal/Secretary

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil